Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT04267393. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Phase 2 Study to Evaluate the Efficacy and Safety of BMS-986263 in Adults With Compensated Cirrhosis From Nonalcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this randomized study is to assess safety and effectiveness of BMS-986263 in adults with compensated cirrhosis (chronic liver disease) from nonalcoholic steatohepatitis (fatty liver disease) (NASH).
Study identification
- NCT ID
- NCT04267393
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 17, 2021 (Actual)
- Primary completion
- Aug 16, 2023 (Actual)
- Completion
- Feb 9, 2024 (Actual)
- Last update posted
- Sep 4, 2024
2021 – 2024
United States locations
- U.S. sites
- 29
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Clinical Trials - Tucson | Chandler | Arizona | 85224 | — |
| Local Institution - 0173 | Chandler | Arizona | 85224 | — |
| The Institute for Liver Health-The Institute for Liver Health | Chandler | Arizona | 85224 | — |
| Local Institution | Phoenix | Arizona | 85013 | — |
| Local Institution - 0140 | La Jolla | California | 92037 | — |
| Local Institution - 0205 | Lancaster | California | 93534 | — |
| GastroIntestinal BioSciences | Los Angeles | California | 90067 | — |
| Local Institution - 0143 | Redwood City | California | 94063 | — |
| Florida Research Institute | Lakewood Rch | Florida | 34211 | — |
| Local Institution - 0024 | Leesburg | Florida | 34748 | — |
| Local Institution - 0061 | Miami | Florida | 33136 | — |
| Local Institution - 0025 | Winter Park | Florida | 32789 | — |
| Local Institution - 0121 | Iowa City | Iowa | 52242 | — |
| Local Institution - 0150 | Baltimore | Maryland | 21202 | — |
| Local Institution | Fall River | Massachusetts | 02721 | — |
| Local Institution - 0077 | Kansas City | Missouri | 64111 | — |
| Local Institution - 0186 | Omaha | Nebraska | 68198 | — |
| Research Foundation of SUNY - University of Buffalo | Buffalo | New York | 14203 | — |
| NYU Langone Health-Department of Medicine | New York | New York | 10016 | — |
| Local Institution | New York | New York | 10029 | — |
| Local Institution - 0206 | Morehead City | North Carolina | 28557 | — |
| Local Institution - 0177 | Philadelphia | Pennsylvania | 19104 | — |
| Local Institution - 0017 | Philadelphia | Pennsylvania | 19107 | — |
| University Diabetes & Endocrine Consultants | Chattanooga | Tennessee | 37411 | — |
| Local Institution - 0171 | Dallas | Texas | 75203 | — |
| Local Institution - 0109 | Houston | Texas | 77030 | — |
| Local Institution | McAllen | Texas | 78504 | — |
| Local Institution - 0013 | San Antonio | Texas | 78215 | — |
| Local Institution - 0122 | Richmond | Virginia | 232980341 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 83 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04267393, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2024 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04267393 live on ClinicalTrials.gov.